Companies: 10,795·Total market cap: $144.5T
Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

PTHSAMEXHealthcare● Active
$26.62
+$1.07(+4.19%)
Market Cap$17263097
P/E Ratio
52W High$54.29
52W Low$10.6

Pelthos Therapeutics Inc.(PTHS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PTHS · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$16.80M$0.00M$0.00M$0.00M$0.00M
Cost of Revenue$9.37M$0.00M$0.00M$0.00M$0.00M
Gross Profit$7.43M$0.00M$0.00M$0.00M$0.00M
Gross Margin %(computed)44.24%
Operating Expenses
R&D Expenses$1.23M$1.18M$2.58M$0.39M$0.21M
G&A Expenses$29.28M$6.39M$4.28M$1.93M$0.63M
Total Operating Expenses$39.86M$7.57M$6.86M$2.32M$0.84M
Operating Income($32.43M)($7.57M)($6.86M)($2.32M)($0.84M)
Operating Margin %(computed)-193.09%
Interest Income$0.01M$0.00M$0.00M$0.00M$0.00M
Interest Expense$3.01M$0.79M$0.52M$0.14M$0.00M
Income Before Tax($50.71M)($7.96M)($7.38M)($2.46M)($0.60M)
Income Tax Expense($7.39M)$0.00M$0.00M$0.00M$0.00M
Net Income($43.32M)($7.96M)($7.38M)($2.46M)($0.60M)
Net Margin %(computed)-257.93%
Per Share & EBITDA
EPS (Basic)$-23.04$-13.54$-12.80$-4.26$-1.00
Wtd Avg Shares1.88M0.59M0.58M0.58M0.58M
EBITDA($45.41M)($7.17M)($6.86M)($2.32M)($0.60M)
EBITDA Margin %(computed)-270.37%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Pelthos Therapeutics Inc.

关于Pelthos Therapeutics Inc.(PTHS)损益表

Pelthos Therapeutics Inc.(PTHS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,PTHS实现营收$0.02B,毛利润$0.01B(毛利率44.24%),净利润($0.04B)(净利率-257.93%)。

常见问题

PTHS · 4 问

Pelthos Therapeutics Inc.(PTHS)2025财年营收为$0.02B,同比up—%。

PTHS revenuePTHS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09